Name
Yashraj Biotechnology Limited
What We Do
Yashraj Biotechnology Ltd. (YBL), headquartered in Mumbai with offices in the US and Germany, is an emerging CRO specializing in preclinical drug discovery. Our expertise lies in developing human induced pluripotent stem cell (hiPSC)-based models and products for disease research, advancing human relevance in preclinical testing. Supported by a state-of-the-art GMP facility, YBL offers a comprehensive range of iPSC-derived products and services, including cell-based assays, drug screening, efficacy testing, safety profiling, and disease modeling. With nearly two decades as one of the largest global suppliers of human native antigens for In Vitro Diagnostics (IVD), YBL has built a reputation for unwavering quality and reliability, supporting diagnostic leaders worldwide. This commitment to excellence drives our efforts to push the boundaries of translational research and accelerate the development of next-generation therapeutics.
Website
Product or Service Categories (15)
Acute Toxicology, Chronic Toxicology, Mechanistic Toxicology, Cells/Tissue, CRO—Contract Research Organization, In Vitro, Preclinical, Manufacturing-Custom, Product Development, Research/Testing, Safety/Risk Assessment
First-Time Exhibitor
Yes
New Product or Website Launch
Visit our booth for a demo
Address
Plot No. C-232, TTC Industrial Area
Navi Mumbai,
India
Navi Mumbai,
India